Torrent Pharmaceuticals Limited

NSE:TORNTPHARM.NS

3199.85 (INR) • At close November 8, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) INR.

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Omzet 107,28094,64084,18878,862.377,800.174,618.458,572.756,721.765,193.945,78840,32330,485.125,944.10621,219.67619,160.37816,306.57613,548.48312,987.8549,671.6245,477.527
Kosten van de omzet 54,78027,35025,374.722,35322,525.223,216.717,768.218,885.716,479.814,745.613,004.89,679.19,813.2936,965.3015,709.7525,352.4633,203.2914,534.9333,647.3371,930.535
Brutowinst 52,50067,29058,813.356,509.355,274.951,401.740,804.537,83648,714.131,042.427,318.220,80616,130.81314,254.37513,450.62610,954.11310,345.1928,452.9216,024.2873,546.992
Brutowinstmarge 0.4890.7110.6990.7170.710.6890.6970.6670.7470.6780.6770.6820.6220.6720.7020.6720.7640.6510.6230.648
Onderzoek- en ontwikkelingskosten 5,270312.7386.5251.8925.15,3803,444.93,585.6134149.2173.3242.9566.4241,388.41,202.181,119.039971.571770.148602.458513.832
Algemene en administratieve kosten 7,722.86,137.65,548.85,7946,065.66,1055,845.84,537.72,152.92,159.71,582.81,358.32,530.0175,923.9244,879.0924,682.8333,482.3120144.85275.369
Verkoop- en marketingkosten 11,296.810,269.98,849.17,426.38,073.97,380.36,330.65,6775,716.75,567.64,4843,847.13,172.895000001,595.164859.443
Verkoop-, algemene en administratieve kosten 21,63016,407.514,397.913,220.314,139.513,485.312,176.410,214.77,869.67,727.36,066.85,205.45,702.9125,923.9244,879.0924,682.8333,482.31201,740.016934.812
Overige kosten 58045097.340.31424.622.34.33.59.81.68.3-59.9773,394.7383,732.0782,952.6654,203.8976,430.380.0050.016
Bedrijfskosten 26,90045,94041,119.938,225.640,086.437,71531,39826,997.423,616.222,748.217,793.214,54211,653.43410,707.0629,813.358,754.5378,657.787,200.5285,193.0312,989.526
Bedrijfsresultaat 25,60021,400.217,693.418,227.715,188.513,686.79,406.510,838.625,097.98,294.29,5256,2644,477.3793,547.3133,637.2762,199.5761,687.4121,252.393831.256557.466
Bedrijfsresultaat ratio 0.2390.2260.210.2310.1950.1830.1610.1910.3850.1810.2360.2050.1730.1670.190.1350.1250.0960.0860.102
Totaal overige inkomsten en kosten netto -2,080-2,928.6-5,434.3-2,965.1-3,322.8-8,070.1-96.442.3-1,4601,103.9-1,085.2-448-891.261-120.565-165.092-277.72-196.425-162.024-54.21611.209
Inkomen voor belasting 23,52018,47012,259.115,262.611,865.75,616.69,310.110,880.923,637.99,398.18,439.85,8163,586.1183,426.7483,472.1841,921.8561,490.9871,090.369777.04568.675
Inkomen voor belasting ratio 0.2190.1950.1460.1940.1530.0750.1590.1920.3630.2050.2090.1910.1380.1610.1810.1180.110.0840.080.104
Belastingkosten 6,9606,0204,487.32,743.81,618.51,253.52,528.71,545.16,413.81,888.41,800.71,466.9723.151725.0941,160.23178.16144.22155.237187.82781.056
Nettowinst 16,563.812,452.37,771.812,518.810,247.24,362.86,781.19,335.517,223.87,509.46,638.84,327.62,840.3552,701.6952,311.9531,843.6961,346.767935.132508.627487.619
Nettowinstmarge 0.1540.1320.0920.1590.1320.0580.1160.1650.2640.1640.1650.1420.1090.1270.1210.1130.0990.0720.0530.089
WPA (Winst Per Aandeel) 48.9436.7922.9636.9930.2812.8920.0427.5951.2122.1919.6112.798.397.986.835.453.982.761.51.44
Verwaterde WPA 48.9436.7922.9636.9930.2812.8920.0427.5951.2122.1919.6112.798.397.986.835.453.982.761.51.44
EBITDA 33,68028,87026,155.625,251.122,629.820,014.915,915.915,377.228,777.212,693.59,584.57,3095,562.9924,172.8974,298.1342,622.3732,075.7241,618.0351,124.956791.728
EBITDA ratio 0.3140.3050.3110.320.2910.2680.2720.2710.4410.2770.2380.240.2140.1970.2240.1610.1530.1250.1160.145